NCT00532298 - Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over | Biotech Hunter

Enrollment

1,596

Participants

Timeline

Start Date

September 20, 2007

Primary Completion Date

November 1, 2007

Study Completion Date

November 2, 2007

Conditions

Influenza

Interventions

BIOLOGICAL

GSK Bio's influenza vaccine GSK576389A [NH 2006/07 season]

Single dose, intramuscular injection, GSK Bio's influenza vaccine GSK576389A formulation recommended for the Northern Hemisphere 2006-2007 influenza season.

BIOLOGICAL

GSK Bio's influenza vaccine GSK576389A [NH 2007/08 season]

Single dose, intramuscular injection, GSK Bio's influenza vaccine GSK576389A formulation recommended for the Northern Hemisphere 2007-2008 influenza season.

BIOLOGICAL

Fluarix [NH 2006/07 season]

Single dose, intramuscular injection, Fluarix vaccine formulation recommended for the Northern Hemisphere 2006-2007 influenza season.

BIOLOGICAL

Fluarix [NH 2007/08 season]

Single dose, intramuscular injection, Fluarix vaccine formulation recommended for the Northern Hemisphere 2007-2008 influenza season.

Trial Locations (6)

2317

GSK Investigational Site, Hamar

2408

GSK Investigational Site, Elverum

2860

GSK Investigational Site, Soeborg

4010

GSK Investigational Site, Stavanger

5094

GSK Investigational Site, Bergen

50417

GSK Investigational Site, Tartu